From the Department of Pharmacy Practice and Science, College of Pharmacy; and, Department of Family Medicine, Carver College of Medicine, The University of Iowa, Iowa City (M.E.E.).
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia (E.K.C., R.W., A.M.T., J.R., R.L.W., J.J.M., C.M.R.).
Hypertension. 2020 Dec;76(6):1945-1952. doi: 10.1161/HYPERTENSIONAHA.120.16209. Epub 2020 Nov 2.
High office blood pressure variability (OBPV) in midlife increases the risk of cardiovascular disease (CVD), but the impact of OBPV in older adults without previous CVD is unknown. We conducted a post hoc analysis of ASPREE trial (Aspirin in Reducing Events in the Elderly) participants aged 70-years and older (65 for US minorities) without history of CVD events at baseline, to examine risk of incident CVD associated with long-term, visit-to-visit OBPV. CVD was a prespecified, adjudicated secondary end point in ASPREE. We estimated OBPV using within-individual SD of mean systolic BP from baseline and first 2 annual visits. Cox proportional hazards regression was used to calculate hazard ratios (HR) and 95% CI for associations with CVD events. In 16 475 participants who survived to year 2 without events, those in the highest tertile of OBPV had increased risk of CVD events after adjustment for multiple covariates, when compared with participants in the lowest tertile (HR, 1.36 [95% CI, 1.08-1.70]; =0.01). Similar increased risk was observed for ischemic stroke (HR, 1.56 [95% CI, 1.04-2.33]; =0.03), heart failure hospitalization, or death (HR, 1.73 [95% CI, 1.07-2.79]; =0.02), and all-cause mortality (HR, 1.27 [95% CI, 1.04-1.54]; =0.02). Findings were consistent when stratifying participants by use of antihypertensive drugs, while sensitivity analyses suggested the increased risk was especially for individuals whose BP was uncontrolled during the OBPV estimation period. Our findings support increased OBPV as a risk factor for CVD events in healthy older adults with, or without hypertension, who have not had such events previously. Registration- URL: https://www.clinicaltrials.gov; Unique identifiers: NCT01038583; URL: https://www.isrctn.com; Unique identifiers: ISRCTN83772183.
中年时期的高职务血压变异性(OBPV)会增加心血管疾病(CVD)的风险,但在没有先前 CVD 病史的老年患者中,OBPV 的影响尚不清楚。我们对 ASPREE 试验(老年人中阿司匹林降低事件)的参与者进行了事后分析,这些参与者年龄在 70 岁及以上(美国少数民族为 65 岁),基线时没有 CVD 事件史,以检查与长期、随访间 OBPV 相关的 CVD 事件的发生风险。CVD 是 ASPREE 的一个预先指定的、经裁决的次要终点。我们使用基线和前 2 次年度访视的平均收缩压个体内标准差来估计 OBPV。使用 Cox 比例风险回归计算与 CVD 事件相关的风险比(HR)和 95%CI。在 16475 名无事件生存至第 2 年的参与者中,与最低三分位组相比,OBPV 最高三分位组在调整了多个协变量后,CVD 事件的风险增加(HR,1.36[95%CI,1.08-1.70];=0.01)。同样观察到缺血性卒中和心力衰竭住院或死亡(HR,1.56[95%CI,1.04-2.33];=0.03)和全因死亡率(HR,1.73[95%CI,1.07-2.79];=0.02)的风险增加。当按抗高血压药物的使用对参与者进行分层时,结果是一致的,而敏感性分析表明,这种风险增加尤其见于在 OBPV 估计期间血压不受控制的个体。我们的研究结果支持 OBPV 作为有或没有高血压、以前没有发生过此类事件的健康老年患者发生 CVD 事件的危险因素。注册- URL:https://www.clinicaltrials.gov;唯一标识符:NCT01038583;URL:https://www.isrctn.com;唯一标识符:ISRCTN83772183。